Medscape16h
Dexcom’s 15-day CGM Adds Wear Time, Accuracy to Current G7
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
15.5-day G7 integrated continuous glucose monitor in adults with diabetes shows positive results
In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...
Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Drug Delivery Business3d
Why Dexcom is making a push to bring CGM to more people with type 2 diabetes
Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.
Dexcom receives FDA warning letter for 2 manufacturing sites
Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...
Drug Delivery Business5d
Dexcom study finds that providers prefer tech over medication for type 2 diabetes
Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.
Becker's Hospital Review7d
FDA warns Dexcom over 2 site deficiences
Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and ...
EurekAlert!3d
Accuracy of the 15.5-day G7 integrated continuous glucose monitor in adults with diabetes
In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day Dexcom G7 integrated continuous glucose monitor (CGM) in ...